Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats

Studies were performed to determine if the reported ‘proconvulsant’ action of lithium in rats given cholinergic drugs is related to receptor‐initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1‐14C]arachidonic acid, whic...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 85; no. 6; pp. 1553 - 1562
Main Authors Basselin, Mireille, Chang, Lisa, Seemann, Ruth, Bell, Jane M., Rapoport, Stanley I.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.06.2003
Blackwell
Subjects
Online AccessGet full text
ISSN0022-3042
1471-4159
DOI10.1046/j.1471-4159.2003.01811.x

Cover

Abstract Studies were performed to determine if the reported ‘proconvulsant’ action of lithium in rats given cholinergic drugs is related to receptor‐initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1‐14C]arachidonic acid, which represent this signaling, were measured by quantitative autoradiography in unanesthetized rats at baseline and following administration of subconvulsant doses of the cholinergic muscarinic agonist, arecoline. In rats fed LiCl for 6 weeks to produce a therapeutically relevant brain lithium concentration, the mean baseline values of k* in brain auditory and visual areas were significantly greater than in rats fed control diet. Arecoline at doses of 2 and 5 mg/kg intraperitoneally increased k* in widespread brain areas in rats fed the control diet as well as the LiCl diet. However, the arecoline‐induced increments often were significantly greater in the LiCl‐fed than in the control diet‐fed rats. Lithium's elevation of baseline k* in auditory and visual regions may correspond to its ability in humans to increase auditory and visual evoked responses. Additionally, its augmentation of the k* responses to arecoline may underlie its reported ‘proconvulsant’ action with cholinergic drugs, as arachidonic acid and its eicosanoid metabolites can increase neuronal excitability and seizure propagation.
AbstractList Studies were performed to determine if the reported ‘proconvulsant’ action of lithium in rats given cholinergic drugs is related to receptor‐initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1‐ 14 C]arachidonic acid, which represent this signaling, were measured by quantitative autoradiography in unanesthetized rats at baseline and following administration of subconvulsant doses of the cholinergic muscarinic agonist, arecoline. In rats fed LiCl for 6 weeks to produce a therapeutically relevant brain lithium concentration, the mean baseline values of k* in brain auditory and visual areas were significantly greater than in rats fed control diet. Arecoline at doses of 2 and 5 mg/kg intraperitoneally increased k* in widespread brain areas in rats fed the control diet as well as the LiCl diet. However, the arecoline‐induced increments often were significantly greater in the LiCl‐fed than in the control diet‐fed rats. Lithium's elevation of baseline k* in auditory and visual regions may correspond to its ability in humans to increase auditory and visual evoked responses. Additionally, its augmentation of the k* responses to arecoline may underlie its reported ‘proconvulsant’ action with cholinergic drugs, as arachidonic acid and its eicosanoid metabolites can increase neuronal excitability and seizure propagation.
Studies were performed to determine if the reported `proconvulsant' action of lithium in rats given cholinergic drugs is related to receptor-initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1- super(14) C]arachidonic acid, which represent this signaling, were measured by quantitative autoradiography in unanesthetized rats at baseline and following administration of subconvulsant doses of the cholinergic muscarinic agonist, arecoline. In rats fed LiCl for 6 weeks to produce a therapeutically relevant brain lithium concentration, the mean baseline values of k* in brain auditory and visual areas were significantly greater than in rats fed control diet. Arecoline at doses of 2 and 5 mg/kg intraperitoneally increased k* in widespread brain areas in rats fed the control diet as well as the LiCl diet. However, the arecoline-induced increments often were significantly greater in the LiCl-fed than in the control diet-fed rats. Lithium's elevation of baseline k* in auditory and visual regions may correspond to its ability in humans to increase auditory and visual evoked responses. Additionally, its augmentation of the k* responses to arecoline may underlie its reported `proconvulsant' action with cholinergic drugs, as arachidonic acid and its eicosanoid metabolites can increase neuronal excitability and seizure propagation.
Studies were performed to determine if the reported 'proconvulsant' action of lithium in rats given cholinergic drugs is related to receptor-initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1-14C]arachidonic acid, which represent this signaling, were measured by quantitative autoradiography in unanesthetized rats at baseline and following administration of subconvulsant doses of the cholinergic muscarinic agonist, arecoline. In rats fed LiCl for 6 weeks to produce a therapeutically relevant brain lithium concentration, the mean baseline values of k* in brain auditory and visual areas were significantly greater than in rats fed control diet. Arecoline at doses of 2 and 5 mg/kg intraperitoneally increased k* in widespread brain areas in rats fed the control diet as well as the LiCl diet. However, the arecoline-induced increments often were significantly greater in the LiCl-fed than in the control diet-fed rats. Lithium's elevation of baseline k* in auditory and visual regions may correspond to its ability in humans to increase auditory and visual evoked responses. Additionally, its augmentation of the k* responses to arecoline may underlie its reported 'proconvulsant' action with cholinergic drugs, as arachidonic acid and its eicosanoid metabolites can increase neuronal excitability and seizure propagation.
Studies were performed to determine if the reported 'proconvulsant' action of lithium in rats given cholinergic drugs is related to receptor-initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1-14C]arachidonic acid, which represent this signaling, were measured by quantitative autoradiography in unanesthetized rats at baseline and following administration of subconvulsant doses of the cholinergic muscarinic agonist, arecoline. In rats fed LiCl for 6 weeks to produce a therapeutically relevant brain lithium concentration, the mean baseline values of k* in brain auditory and visual areas were significantly greater than in rats fed control diet. Arecoline at doses of 2 and 5 mg/kg intraperitoneally increased k* in widespread brain areas in rats fed the control diet as well as the LiCl diet. However, the arecoline-induced increments often were significantly greater in the LiCl-fed than in the control diet-fed rats. Lithium's elevation of baseline k* in auditory and visual regions may correspond to its ability in humans to increase auditory and visual evoked responses. Additionally, its augmentation of the k* responses to arecoline may underlie its reported 'proconvulsant' action with cholinergic drugs, as arachidonic acid and its eicosanoid metabolites can increase neuronal excitability and seizure propagation.Studies were performed to determine if the reported 'proconvulsant' action of lithium in rats given cholinergic drugs is related to receptor-initiated phospholipase A2 signaling via arachidonic acid. Regional brain incorporation coefficients k* of intravenously injected [1-14C]arachidonic acid, which represent this signaling, were measured by quantitative autoradiography in unanesthetized rats at baseline and following administration of subconvulsant doses of the cholinergic muscarinic agonist, arecoline. In rats fed LiCl for 6 weeks to produce a therapeutically relevant brain lithium concentration, the mean baseline values of k* in brain auditory and visual areas were significantly greater than in rats fed control diet. Arecoline at doses of 2 and 5 mg/kg intraperitoneally increased k* in widespread brain areas in rats fed the control diet as well as the LiCl diet. However, the arecoline-induced increments often were significantly greater in the LiCl-fed than in the control diet-fed rats. Lithium's elevation of baseline k* in auditory and visual regions may correspond to its ability in humans to increase auditory and visual evoked responses. Additionally, its augmentation of the k* responses to arecoline may underlie its reported 'proconvulsant' action with cholinergic drugs, as arachidonic acid and its eicosanoid metabolites can increase neuronal excitability and seizure propagation.
Author Bell, Jane M.
Basselin, Mireille
Chang, Lisa
Seemann, Ruth
Rapoport, Stanley I.
Author_xml – sequence: 1
  givenname: Mireille
  surname: Basselin
  fullname: Basselin, Mireille
– sequence: 2
  givenname: Lisa
  surname: Chang
  fullname: Chang, Lisa
– sequence: 3
  givenname: Ruth
  surname: Seemann
  fullname: Seemann, Ruth
– sequence: 4
  givenname: Jane M.
  surname: Bell
  fullname: Bell, Jane M.
– sequence: 5
  givenname: Stanley I.
  surname: Rapoport
  fullname: Rapoport, Stanley I.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14875565$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12787074$$D View this record in MEDLINE/PubMed
BookMark eNqNkU2P0zAQhi20iO0u_AXkC9waPLbjpAeQUMWnVnCBs-XYTjslcYrt7MeZP07SlkXiwp488jzvO6N5L8hZGIInhAIrgEn1aleArGApoVwVnDFRMKgBittHZHHfOCMLxjhfCib5OblIaccYKKngCTkHXtUVq-SC_Fpv4xDQ0g7zFseeGtdjwJSjyTgEuh-yDxlN9ok20WCgJhq7RXcQGYuOJtwE02HYUJNp9ClTExx1Y5y_7HaYWj5uDnTG66Pt7HNjfng6jUlPyePWdMk_O72X5Pv7d9_WH5dXXz98Wr-9WlpZKVi2wrN6VVkrrOJNo2ypgDtecqe4Bdk2DrhwjeBCQtUoKVvuXS2V5bJUXq3EJXl59N3H4ec4Lap7TNZ3nQl-GJOuhBCyfgAI9UqUoGACn5_Asem90_uIvYl3-s99J-DFCTDJmq6NJlhMfzlZV2Wpyol7c-RsHFKKvtUW8-FUUxDYaWB6Dl7v9JyvnvPVc_D6ELy-nQzqfwzuZ_xf-voovcHO3z1Ypz9_Wc-V-A3stMZC
CODEN JONRA9
CitedBy_id crossref_primary_10_1124_pr_58_3_7
crossref_primary_10_1021_cn500058v
crossref_primary_10_1093_nar_gkq107
crossref_primary_10_1016_j_brainresbull_2006_03_006
crossref_primary_10_1016_j_neuroscience_2017_10_024
crossref_primary_10_1016_j_brainresbull_2011_12_001
crossref_primary_10_1111_j_1471_4159_2011_07198_x
crossref_primary_10_1038_mp_2008_31
crossref_primary_10_1038_sj_npp_1300671
crossref_primary_10_1007_s00213_006_0582_1
crossref_primary_10_1016_j_biopsych_2005_07_024
crossref_primary_10_1016_j_brainresrev_2009_06_003
crossref_primary_10_1038_sj_npp_1300611
crossref_primary_10_2174_1570164617999200519100634
crossref_primary_10_1007_s00213_005_2189_3
crossref_primary_10_1038_sj_npp_1300920
crossref_primary_10_1007_s00213_006_0425_0
crossref_primary_10_1016_j_plipres_2011_06_001
crossref_primary_10_1016_j_seizure_2016_07_013
crossref_primary_10_1017_S146114570900025X
crossref_primary_10_1111_j_1471_4159_2005_03612_x
crossref_primary_10_1007_s11064_007_9372_3
crossref_primary_10_1042_BST0371104
crossref_primary_10_1016_j_plefa_2021_102247
crossref_primary_10_1007_s11481_012_9381_0
crossref_primary_10_1016_j_brainres_2014_11_059
crossref_primary_10_1016_j_biopsych_2006_03_022
crossref_primary_10_1111_j_1471_4159_2004_02786_x
crossref_primary_10_1111_j_1471_4159_2007_04593_x
crossref_primary_10_1242_dmm_008391
crossref_primary_10_1007_s00213_005_2231_5
crossref_primary_10_2174_1570159X20666220411081728
crossref_primary_10_1194_jlr_R300013_JLR200
crossref_primary_10_1007_s11064_008_9700_2
crossref_primary_10_1097_MCO_0b013e328336b615
crossref_primary_10_1194_jlr_C500003_JLR200
Cites_doi 10.1016/0006-8993(95)01306-7
10.1111/j.1471-4159.1990.tb08813.x
10.1139/cjpp-78-5-392
10.1111/j.1749-6632.1967.tb13719.x
10.1096/fasebj.9.8.7768353
10.1016/0014-4886(87)90293-7
10.1038/sj.npp.1300022
10.1159/000137996
10.1046/j.1471-4159.1996.67020822.x
10.1016/S0090-6980(97)00122-6
10.1016/0006-8993(87)90352-0
10.1097/00001756-199405000-00024
10.1016/0006-3223(85)90132-5
10.1016/0165-0327(90)90046-B
10.1073/pnas.88.15.6477
10.1172/JCI13241
10.1016/0898-6568(89)90067-3
10.1073/pnas.87.6.2187
10.1212/WNL.31.5.517
10.1016/0006-8993(89)90830-5
10.1111/j.1471-4159.1991.tb02603.x
10.1016/S0898-6568(99)00006-6
10.1002/jnr.490180311
10.1016/S0028-3908(98)00197-X
10.1067/S0022-3476(03)00399-8
10.1016/S0361-9230(01)00744-4
10.1016/0197-0186(94)90124-4
10.1016/0304-3940(90)90635-M
10.1016/S0014-2999(01)01343-7
10.1016/0014-4886(88)90198-7
10.1042/bj3230281
10.1016/0006-3223(89)90180-7
10.1212/WNL.32.9.921
10.1385/JMN:16:2-3:243
10.1074/jbc.271.51.32722
10.1016/S0002-9440(10)65199-1
10.1016/S0021-9258(18)64849-5
10.1111/j.1471-4159.1992.tb10964.x
10.1016/0006-8993(95)00395-7
10.1016/0306-4522(90)90042-3
10.1046/j.1460-9568.2001.01420.x
10.1007/BF00176787
10.1159/000117876
10.1016/0006-3223(90)90449-C
10.1016/0014-4886(91)90103-J
10.1023/A:1027341707837
10.1152/jn.00768.2000
10.1016/S0079-6123(08)62414-0
10.1016/0165-0173(92)90016-F
10.1111/j.1469-7793.1999.00101.x
10.1016/0024-3205(93)90300-R
10.1023/A:1020788031720
10.1016/0006-291X(86)90395-5
10.1111/j.1749-6632.1989.tb22594.x
10.1152/ajpgi.00345.2002
10.1016/0014-2999(87)90813-2
10.1006/bbrc.1993.2474
10.1016/S0006-291X(88)80747-2
10.1016/S0304-3940(96)13264-X
10.1007/978-1-4615-3426-6_21
10.1111/j.1471-4159.1977.tb10649.x
10.1089/089771502753754091
10.1111/j.1471-4159.1992.tb09273.x
10.1016/0013-4694(83)90164-5
10.1016/0028-3908(82)90180-0
10.1111/j.1600-0773.1982.tb01054.x
10.1111/j.1471-4159.1979.tb05179.x
10.1016/S0028-3908(98)00024-0
ContentType Journal Article
Copyright 2003 INIST-CNRS
Copyright_xml – notice: 2003 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
DOI 10.1046/j.1471-4159.2003.01811.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
Neurosciences Abstracts
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1471-4159
EndPage 1562
ExternalDocumentID 12787074
14875565
10_1046_j_1471_4159_2003_01811_x
JNC1811
Genre article
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29L
2WC
31~
33P
36B
3SF
4.4
41~
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYJJ
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOD
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GAKWD
GODZA
GX1
H.X
HF~
HGLYW
HH5
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TWZ
UB1
V8K
VH1
W8V
W99
WBKPD
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOW
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XJT
YFH
YNH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7TK
7X8
ID FETCH-LOGICAL-c4761-f3e0897cc3c62bb6c5612d252d62c14fbd123db323417b644f2ed846c2456e693
IEDL.DBID DR2
ISSN 0022-3042
IngestDate Thu Jul 10 18:11:23 EDT 2025
Fri Jul 11 05:30:59 EDT 2025
Wed Feb 19 02:34:51 EST 2025
Mon Jul 21 09:16:24 EDT 2025
Tue Jul 01 02:14:44 EDT 2025
Thu Apr 24 23:08:25 EDT 2025
Wed Jan 22 17:10:50 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Rat
Enzyme
phospholipase A2
Rodentia
Central nervous system
Excitability
Lithium
Esterases
Arachidonic acid
brain
Phospholipase A
Carboxylic ester hydrolases
Signal transduction
muscarinic
Cholinergic receptor
Vertebrata
Mammalia
Neuron
Eicosanoid
Hydrolases
Muscarinic receptor
Brain (vertebrata)
stimulation
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4761-f3e0897cc3c62bb6c5612d252d62c14fbd123db323417b644f2ed846c2456e693
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1471-4159.2003.01811.x
PMID 12787074
PQID 18935161
PQPubID 23462
PageCount 10
ParticipantIDs proquest_miscellaneous_73334869
proquest_miscellaneous_18935161
pubmed_primary_12787074
pascalfrancis_primary_14875565
crossref_citationtrail_10_1046_j_1471_4159_2003_01811_x
crossref_primary_10_1046_j_1471_4159_2003_01811_x
wiley_primary_10_1046_j_1471_4159_2003_01811_x_JNC1811
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2003
PublicationDateYYYYMMDD 2003-06-01
PublicationDate_xml – month: 06
  year: 2003
  text: June 2003
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle Journal of neurochemistry
PublicationTitleAlternate J Neurochem
PublicationYear 2003
Publisher Blackwell Science Ltd
Blackwell
Publisher_xml – name: Blackwell Science Ltd
– name: Blackwell
References 1987; 140
1990; 55
1996; 709
1989; 559
1991; 111
2002; 19
1991; 56
1957; 226
1986; 134
1977; 28
1997; 85
1982; 51
2002; 57
1993; 64
1992; 17
1994; 24
1988; 100
1999; 520
1984; 29
1996; 220
1992; 58
2001; 107
1979; 33
1985; 20
2001; 428
1983; 55
1990; 87
1994; 269
1997; 54
1991; 88
1982; 21
2002; 87
1987
1999; 11
1982; 8
1967; 142
1992; 318
2001; 16
1995; 685
1981
1990; 255
2001; 13
1981; 31
1996; 67
2003; 284
1995; 9
1994; 232
1987; 97
1989; 1
1997; 22
1990; 38
1993; 43
1982; 32
1996
1987; 408
2003
1989; 25
1998; 23
1987; 18
1998; 37
1990; 118
1990; 20
1991; 27
1990; 27
1989; 487
2000; 78
1993; 98
1999; 38
1993; 52
1996; 271
1988; 156
2003; 28
1999; 155
1994; 5
1993; 197
Lenox R. H. (e_1_2_22_38_1) 1991; 27
e_1_2_22_71_1
e_1_2_22_73_1
e_1_2_22_75_1
Yasuda R. P. (e_1_2_22_76_1) 1993; 43
e_1_2_22_28_1
e_1_2_22_77_1
e_1_2_22_26_1
e_1_2_22_49_1
e_1_2_22_58_1
e_1_2_22_14_1
e_1_2_22_35_1
e_1_2_22_8_1
e_1_2_22_56_1
e_1_2_22_12_1
e_1_2_22_33_1
e_1_2_22_54_1
e_1_2_22_10_1
e_1_2_22_31_1
e_1_2_22_52_1
Ehlert F. J. (e_1_2_22_13_1) 1990; 255
e_1_2_22_60_1
e_1_2_22_62_1
e_1_2_22_3_1
e_1_2_22_19_1
e_1_2_22_64_1
e_1_2_22_17_1
e_1_2_22_66_1
e_1_2_22_7_1
e_1_2_22_15_1
e_1_2_22_68_1
e_1_2_22_24_1
e_1_2_22_47_1
e_1_2_22_59_1
e_1_2_22_22_1
e_1_2_22_45_1
e_1_2_22_20_1
e_1_2_22_43_1
e_1_2_22_41_1
Cooper J. R. (e_1_2_22_11_1) 1996
Paxinos G. (e_1_2_22_50_1) 1987
e_1_2_22_70_1
e_1_2_22_72_1
e_1_2_22_74_1
e_1_2_22_29_1
e_1_2_22_57_1
e_1_2_22_27_1
e_1_2_22_48_1
e_1_2_22_36_1
e_1_2_22_34_1
e_1_2_22_9_1
e_1_2_22_55_1
Hambrecht M. (e_1_2_22_25_1) 1993; 64
e_1_2_22_32_1
e_1_2_22_53_1
Tence M. (e_1_2_22_69_1) 1994; 269
e_1_2_22_30_1
e_1_2_22_51_1
e_1_2_22_61_1
e_1_2_22_2_1
e_1_2_22_63_1
e_1_2_22_65_1
e_1_2_22_6_1
e_1_2_22_18_1
e_1_2_22_39_1
e_1_2_22_67_1
e_1_2_22_4_1
e_1_2_22_16_1
e_1_2_22_37_1
e_1_2_22_46_1
e_1_2_22_23_1
e_1_2_22_44_1
e_1_2_22_21_1
e_1_2_22_42_1
e_1_2_22_40_1
Brodal A. (e_1_2_22_5_1) 1981
References_xml – volume: 107
  start-page: 1347
  year: 2001
  end-page: 1351
  article-title: Regulated formation of eicosanoids
  publication-title: J. Clin. Invest.
– volume: 98
  start-page: 317
  year: 1993
  end-page: 322
  article-title: Lithium selectively potentiates cholinergic activity in rat brain
  publication-title: Prog. Brain Res.
– volume: 54
  start-page: 511
  year: 1997
  end-page: 530
  article-title: Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes
  publication-title: Prostaglandins
– volume: 32
  start-page: 921
  year: 1982
  end-page: 937
  article-title: Tomographic mapping of human cerebral metabolism: auditory stimulation
  publication-title: Neurol.
– volume: 1
  start-page: 587
  year: 1989
  end-page: 598
  article-title: Bradykinin effects on phospholipid metabolism and its relation to arachidonic acid turnover in neuroblastoma x glioma hybrid cells (NG 108–15)
  publication-title: Cellular Signaling
– volume: 520
  start-page: 101
  year: 1999
  end-page: 111
  article-title: Muscarinic M1 receptors activate phosphoinositide turnover and Ca mobilization in rat sympathetic neurones, but this signaling pathway does not mediate M‐current inhibition
  publication-title: J. Physiol.
– year: 1981
– volume: 37
  start-page: 357
  year: 1998
  end-page: 374
  article-title: Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioral and autoradiographic study
  publication-title: Neuropharmacology
– volume: 269
  start-page: 646
  year: 1994
  end-page: 653
  article-title: Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 9
  start-page: 619
  year: 1995
  end-page: 625
  article-title: Muscarinic acetylcholine receptors: signal transduction through multiple effectors
  publication-title: FASEB J.
– volume: 100
  start-page: 23
  year: 1988
  end-page: 39
  article-title: Visual thalamocortical projections in normal and enucleated rats: HRP and fluorescent dye studies
  publication-title: Exp. Neurol.
– volume: 226
  start-page: 497
  year: 1957
  end-page: 509
  article-title: A simple method for the isolation and purification of total lipides from animal tissues
  publication-title: J. Biol. Chem.
– volume: 38
  start-page: 403
  year: 1999
  end-page: 414
  article-title: Effects of lithium on receptor‐mediated activation of G proteins in rat brain cortical membranes
  publication-title: Neuropharmacology
– volume: 67
  start-page: 822
  year: 1996
  end-page: 829
  article-title: Preferential incorporation of [ H]arachidonic acid from blood into rat brain synaptosomal fractions before and after cholinergic stimulation
  publication-title: J. Neurochem.
– volume: 20
  start-page: 20
  year: 1985
  end-page: 40
  article-title: Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium
  publication-title: Biol. Psychiatry
– volume: 142
  start-page: 126
  year: 1967
  end-page: 142
  article-title: Arecoline, nicotine, and related compounds: tremorgenic activity and effect upon brain acetylcholine
  publication-title: Ann. NY Acad. Sci.
– volume: 87
  start-page: 912
  year: 2002
  end-page: 924
  article-title: Partial ablations of the flocculus and ventral paraflocculus in monkeys cause linked deficits in smooth pursuit eye movements and adaptive modification of the VOR
  publication-title: J. Neurophysiol.
– volume: 78
  start-page: 392
  year: 2000
  end-page: 399
  article-title: Enhancement of hippocampal cholinergic neurotransmission through 5‐HT1A receptor‐mediated pathways by repeated lithium treatment in rats
  publication-title: Can. J. Physiol. Pharmacol.
– volume: 17
  start-page: 187
  year: 1992
  end-page: 214
  article-title: A quantitative method for measuring regional fatty‐acid incorporation into and turnover within brain phospholipids: Review and critical analysis
  publication-title: Brain Res. Rev.
– volume: 51
  start-page: 1
  year: 1982
  end-page: 5
  article-title: The influence of age and sex on weight variation in rats treated chronically with lithium chloride
  publication-title: Acta Pharmacol. Toxicol. (Copenhagen)
– volume: 25
  start-page: 329
  year: 1989
  end-page: 340
  article-title: Long‐term lithium treatment selectively reduces receptor‐coupled inositol phospholipid hydrolysis in rat brain
  publication-title: Biol. Psychiatry
– volume: 58
  start-page: 18
  year: 1992
  end-page: 38
  article-title: Inositol lipids and signal transduction in the nervous system: an update
  publication-title: J. Neurochem.
– volume: 118
  start-page: 235
  year: 1990
  end-page: 237
  article-title: Muscarinic receptors mediate the release of arachidonic acid from spinal cord and hippocampal neurons in primary culture
  publication-title: Neurosci. Let.
– year: 2003
  article-title: Quantifying and imaging brain arachidonoic and docosahexaenoic acid metabolism
  publication-title: J. Pediat.
– volume: 27
  start-page: 555
  year: 1990
  end-page: 560
  article-title: Effects of lithium on auditory evoked potentials in healthy subjects
  publication-title: Biol. Psychiatry
– volume: 64
  start-page: 747
  year: 1993
  end-page: 749
  article-title: Pseudo‐hallucinations after long‐term lithium treatment [in German]
  publication-title: Nervenarzt
– volume: 22
  start-page: 663
  year: 1997
  end-page: 670
  article-title: Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse
  publication-title: Neurochem. Res.
– volume: 155
  start-page: 995
  year: 1999
  end-page: 1004
  article-title: Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase‐2
  publication-title: Am. J. Pathol.
– volume: 28
  start-page: 897
  year: 1977
  end-page: 916
  article-title: The [ C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat
  publication-title: J. Neurochem.
– volume: 97
  start-page: 193
  year: 1987
  end-page: 200
  article-title: Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium‐pretreated rats
  publication-title: Exp. Neurol.
– volume: 28
  start-page: 244
  year: 2003
  end-page: 252
  article-title: Imaging brain phospholipase A activation in awake rats in response to the 5‐HT agonist (+/–) 2,5‐dimethoxy‐4‐iodophenyl‐2‐aminopropane (DOI)
  publication-title: Neuropsychopharmacology
– volume: 19
  start-page: 627
  year: 2002
  end-page: 638
  article-title: Cyclooxygenase‐2 inhibition protects cultured cerebellar granule neurons from glutamate‐mediated cell death
  publication-title: J. Neurotrauma
– volume: 55
  start-page: 1
  year: 1990
  end-page: 15
  article-title: Arachidonic acid cascade and signal transduction
  publication-title: J. Neurochem.
– volume: 29
  start-page: 85
  year: 1984
  end-page: 93
  article-title: Effect of prostaglandin synthetase inhibitors on experimentally induced convulsions in rats
  publication-title: Pharmacology
– volume: 428
  start-page: 303
  year: 2001
  end-page: 309
  article-title: Effects of subchronic lithium chloride treatment on G‐protein subunits (Golf, Ggamma7) and adenylyl cyclase expressed specifically in the rat striatum
  publication-title: Eur. J. Pharmacol.
– volume: 56
  start-page: 352
  year: 1991
  end-page: 355
  article-title: Arecoline‐stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats
  publication-title: J. Neurochem.
– volume: 88
  start-page: 6477
  year: 1991
  end-page: 6480
  article-title: A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP‐mediated arachidonic acid release
  publication-title: Proc. Natl Acad. Sci. USA
– volume: 487
  start-page: 255
  year: 1989
  end-page: 266
  article-title: Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer‐344 rats
  publication-title: Brain Res.
– volume: 318
  start-page: 251
  year: 1992
  end-page: 258
  article-title: Carbachol‐stimulated release of arachidonic acid and eicosanoids from brain cortex synaptoneurosome lipids of adult and aged rats
  publication-title: Adv. Exp. Med. Biol.
– volume: 85
  start-page: 281
  year: 1997
  end-page: 287
  article-title: Cytosolic phospholipase A is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism
  publication-title: Biochem. J.
– volume: 197
  start-page: 292
  year: 1993
  end-page: 297
  article-title: Phospholipase A activation influences the processing and secretion of the amyloid precursor protein
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 8
  start-page: 41
  year: 1982
  end-page: 50
  article-title: Effect of lithium on circadian neurotransmitter receptor rhythms
  publication-title: Neuropsychobiology
– volume: 20
  start-page: 19
  year: 1990
  end-page: 25
  article-title: Effect of lithium on the dynamics of electroencephalographic vigilance in healthy subjects
  publication-title: J. Affect. Disord.
– volume: 271
  start-page: 32722
  year: 1996
  end-page: 32728
  article-title: Synergy by secretory phospholipase A and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures
  publication-title: J. Biol. Chem.
– volume: 220
  start-page: 171
  year: 1996
  end-page: 174
  article-title: Lithium decreases turnover of arachidonate in several brain phospholipids
  publication-title: Neurosci. Lett.
– volume: 21
  start-page: 1199
  year: 1982
  end-page: 1201
  article-title: The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation
  publication-title: Neuropharmacology
– volume: 57
  start-page: 205
  year: 2002
  end-page: 209
  article-title: Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration
  publication-title: Brain Res. Bull.
– volume: 111
  start-page: 356
  year: 1991
  end-page: 361
  article-title: Analysis of the convulsant‐potentiating effects of lithium in rats
  publication-title: Exp. Neurol.
– volume: 52
  start-page: 441
  year: 1993
  end-page: 448
  article-title: Immunological localization of m1‐m5 muscarinic acetylcholine receptors in peripheral tissues and brain
  publication-title: Life Sci.
– volume: 58
  start-page: 2200
  year: 1992
  end-page: 2206
  article-title: Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions
  publication-title: J. Neurochem.
– volume: 43
  start-page: 149
  year: 1993
  end-page: 157
  article-title: Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain
  publication-title: Mol. Pharmacol.
– year: 1987
– volume: 23
  start-page: 1251
  year: 1998
  end-page: 1257
  article-title: Manoalide, a phospholipase A inhibitor, inhibits arachidonate incorporation and turnover in brain phospholipids of the awake rat
  publication-title: Neurochem. Res.
– volume: 5
  start-page: 1118
  year: 1994
  end-page: 1120
  article-title: Lithium potentiates phosphoinositide‐linked 5‐HT receptor stimulation
  publication-title: Neuroreport
– year: 1996
– volume: 13
  start-page: 569
  year: 2001
  end-page: 575
  article-title: The selective cyclooxygenase‐2 inhibitor rofecoxib reduces kainate‐induced cell death in the rat hippocampus
  publication-title: Eur. J. Neurosci.
– volume: 284
  start-page: G472
  year: 2003
  end-page: G480
  article-title: Erk1/2‐ and p38 MAP kinase‐dependent phosphorylation and activation of cPLA2 by m3 and m2 receptors
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
– volume: 11
  start-page: 405
  year: 1999
  end-page: 413
  article-title: Arachidonic acid release in cell lines transfected with muscarinic receptors: a simple functional assay to determine response of agonists
  publication-title: Cell Signal.
– volume: 38
  start-page: 457
  year: 1990
  end-page: 468
  article-title: Lithium enhances neuronal musarinic excitation by presynaptic facilitation
  publication-title: Neuroscience
– volume: 408
  start-page: 6
  year: 1987
  end-page: 12
  article-title: Evidence for increased activity of mouse brain fatty acid cyclooxygenase following drug‐induced convulsions
  publication-title: Brain Res.
– volume: 87
  start-page: 2187
  year: 1990
  end-page: 2191
  article-title: Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis
  publication-title: Proc. Natl Acad. Sci. USA
– volume: 55
  start-page: 538
  year: 1983
  end-page: 545
  article-title: Changes in the visual evoked potential to pattern reversal with lithium medication
  publication-title: Electroencephalogr. Clin. Neurophysiol.
– volume: 18
  start-page: 449
  year: 1987
  end-page: 455
  article-title: Arachidonic acid, stearic acid, and diacylglycerol accumulation correlates with the loss of phosphatidylinositol 4,5‐bisphosphate in cerebrum 2 seconds after electroconvulsive shock: Complete reversion of changes 5 minutes after stimulation
  publication-title: J. Neurosci. Res.
– volume: 255
  start-page: 1148
  year: 1990
  end-page: 1157
  article-title: Regional distribution of M1, M2 and non‐M1, non‐M2 subtypes of muscarinic binding sites in rat brain
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 559
  start-page: 1
  year: 1989
  end-page: 16
  article-title: Arachidonic acid in the modulation of excitable membrane function and at the onset of brain damage
  publication-title: Ann. NY Acad. Sci.
– volume: 33
  start-page: 487
  year: 1979
  end-page: 495
  article-title: Effects of lithium treatment and on acetylcholine metabolism in rat brain
  publication-title: J. Neurochem.
– volume: 709
  start-page: 251
  year: 1996
  end-page: 258
  article-title: Demonstration of direct input from the retina to the lateral habenular nucleus in the albino rat
  publication-title: Brain Res.
– volume: 27
  start-page: 191
  year: 1991
  end-page: 197
  article-title: Muscarinic receptor regulation and protein kinase C: Sites for the action of chronic lithium in the hippocampus
  publication-title: Psychopharmacol. Bull.
– volume: 140
  start-page: 245
  year: 1987
  end-page: 246
  article-title: Chronic lithium treatment reduces norepinephrine‐stimulated inositol phospholipid hydrolysis in rat cortex
  publication-title: Eur. J. Pharmacol.
– volume: 24
  start-page: 13
  year: 1994
  end-page: 22
  article-title: Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets
  publication-title: Neurochem. Int.
– volume: 16
  start-page: 243
  year: 2001
  end-page: 261
  article-title: fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling
  publication-title: J. Mol. Neurosci.
– volume: 31
  start-page: 517
  year: 1981
  end-page: 529
  article-title: Tomographic mapping of human cerebral metabolism: visual stimulation and deprivation
  publication-title: Neurology
– volume: 156
  start-page: 1111
  year: 1988
  end-page: 1119
  article-title: Light‐induced phosphoinositide degradation and light‐induced structural alterations in the rat retina are enhanced after chronic lithium treatment
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 134
  start-page: 1327
  year: 1986
  end-page: 1333
  article-title: Diacylglycerol lipase pathway is a minor source of released arachidonic acid in thrombin‐stimulated human platelets
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 685
  start-page: 169
  year: 1995
  end-page: 178
  article-title: Modulation by inositol of cholinergic‐ and serotonergic‐induced seizures in lithium‐treated rats
  publication-title: Brain Res.
– volume: 232
  start-page: 167
  year: 1994
  end-page: 175
  article-title: Light‐evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light‐evoked arachidonic acid release
  publication-title: Graefes Arch. Clin. Exp. Ophthalmol.
– ident: e_1_2_22_53_1
  doi: 10.1016/0006-8993(95)01306-7
– ident: e_1_2_22_61_1
  doi: 10.1111/j.1471-4159.1990.tb08813.x
– ident: e_1_2_22_23_1
  doi: 10.1139/cjpp-78-5-392
– ident: e_1_2_22_27_1
  doi: 10.1111/j.1749-6632.1967.tb13719.x
– ident: e_1_2_22_16_1
  doi: 10.1096/fasebj.9.8.7768353
– ident: e_1_2_22_48_1
  doi: 10.1016/0014-4886(87)90293-7
– ident: e_1_2_22_54_1
  doi: 10.1038/sj.npp.1300022
– ident: e_1_2_22_71_1
  doi: 10.1159/000137996
– ident: e_1_2_22_28_1
  doi: 10.1046/j.1471-4159.1996.67020822.x
– ident: e_1_2_22_42_1
  doi: 10.1016/S0090-6980(97)00122-6
– ident: e_1_2_22_43_1
  doi: 10.1016/0006-8993(87)90352-0
– volume: 269
  start-page: 646
  year: 1994
  ident: e_1_2_22_69_1
  article-title: Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture
  publication-title: J. Pharmacol. Exp. Ther.
– ident: e_1_2_22_74_1
  doi: 10.1097/00001756-199405000-00024
– ident: e_1_2_22_39_1
  doi: 10.1016/0006-3223(85)90132-5
– ident: e_1_2_22_70_1
  doi: 10.1016/0165-0327(90)90046-B
– ident: e_1_2_22_18_1
  doi: 10.1073/pnas.88.15.6477
– volume-title: The Rat Brain in Stereotaxic Coordinates
  year: 1987
  ident: e_1_2_22_50_1
– ident: e_1_2_22_21_1
  doi: 10.1172/JCI13241
– ident: e_1_2_22_62_1
  doi: 10.1016/0898-6568(89)90067-3
– ident: e_1_2_22_17_1
  doi: 10.1073/pnas.87.6.2187
– ident: e_1_2_22_52_1
  doi: 10.1212/WNL.31.5.517
– ident: e_1_2_22_64_1
  doi: 10.1016/0006-8993(89)90830-5
– ident: e_1_2_22_12_1
  doi: 10.1111/j.1471-4159.1991.tb02603.x
– ident: e_1_2_22_6_1
  doi: 10.1016/S0898-6568(99)00006-6
– ident: e_1_2_22_58_1
  doi: 10.1002/jnr.490180311
– ident: e_1_2_22_72_1
  doi: 10.1016/S0028-3908(98)00197-X
– ident: e_1_2_22_57_1
  doi: 10.1067/S0022-3476(03)00399-8
– ident: e_1_2_22_4_1
  doi: 10.1016/S0361-9230(01)00744-4
– ident: e_1_2_22_7_1
  doi: 10.1016/0197-0186(94)90124-4
– ident: e_1_2_22_34_1
  doi: 10.1016/0304-3940(90)90635-M
– volume: 27
  start-page: 191
  year: 1991
  ident: e_1_2_22_38_1
  article-title: Muscarinic receptor regulation and protein kinase C: Sites for the action of chronic lithium in the hippocampus
  publication-title: Psychopharmacol. Bull.
– ident: e_1_2_22_46_1
  doi: 10.1016/S0014-2999(01)01343-7
– ident: e_1_2_22_73_1
  doi: 10.1016/0014-4886(88)90198-7
– ident: e_1_2_22_2_1
  doi: 10.1042/bj3230281
– ident: e_1_2_22_9_1
  doi: 10.1016/0006-3223(89)90180-7
– volume-title: The Biochemical Basis of Neuropharmacology
  year: 1996
  ident: e_1_2_22_11_1
– ident: e_1_2_22_45_1
  doi: 10.1212/WNL.32.9.921
– ident: e_1_2_22_56_1
  doi: 10.1385/JMN:16:2-3:243
– ident: e_1_2_22_36_1
  doi: 10.1074/jbc.271.51.32722
– volume-title: Neurological Anatomy in Relation to Clinical Medicine
  year: 1981
  ident: e_1_2_22_5_1
– ident: e_1_2_22_35_1
  doi: 10.1016/S0002-9440(10)65199-1
– ident: e_1_2_22_22_1
  doi: 10.1016/S0021-9258(18)64849-5
– ident: e_1_2_22_65_1
  doi: 10.1111/j.1471-4159.1992.tb10964.x
– ident: e_1_2_22_75_1
  doi: 10.1016/0006-8993(95)00395-7
– ident: e_1_2_22_15_1
  doi: 10.1016/0306-4522(90)90042-3
– ident: e_1_2_22_37_1
  doi: 10.1046/j.1460-9568.2001.01420.x
– ident: e_1_2_22_32_1
  doi: 10.1007/BF00176787
– ident: e_1_2_22_33_1
  doi: 10.1159/000117876
– ident: e_1_2_22_26_1
  doi: 10.1016/0006-3223(90)90449-C
– volume: 255
  start-page: 1148
  year: 1990
  ident: e_1_2_22_13_1
  article-title: Regional distribution of M1, M2 and non‐M1, non‐M2 subtypes of muscarinic binding sites in rat brain
  publication-title: J. Pharmacol. Exp. Ther.
– ident: e_1_2_22_49_1
  doi: 10.1016/0014-4886(91)90103-J
– volume: 43
  start-page: 149
  year: 1993
  ident: e_1_2_22_76_1
  article-title: Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain
  publication-title: Mol. Pharmacol.
– ident: e_1_2_22_29_1
  doi: 10.1023/A:1027341707837
– ident: e_1_2_22_55_1
  doi: 10.1152/jn.00768.2000
– ident: e_1_2_22_31_1
  doi: 10.1016/S0079-6123(08)62414-0
– ident: e_1_2_22_60_1
  doi: 10.1016/0165-0173(92)90016-F
– ident: e_1_2_22_59_1
  doi: 10.1111/j.1469-7793.1999.00101.x
– ident: e_1_2_22_40_1
  doi: 10.1016/0024-3205(93)90300-R
– ident: e_1_2_22_24_1
  doi: 10.1023/A:1020788031720
– ident: e_1_2_22_44_1
  doi: 10.1016/0006-291X(86)90395-5
– ident: e_1_2_22_3_1
  doi: 10.1111/j.1749-6632.1989.tb22594.x
– ident: e_1_2_22_77_1
  doi: 10.1152/ajpgi.00345.2002
– ident: e_1_2_22_8_1
  doi: 10.1016/0014-2999(87)90813-2
– ident: e_1_2_22_14_1
  doi: 10.1006/bbrc.1993.2474
– ident: e_1_2_22_51_1
  doi: 10.1016/S0006-291X(88)80747-2
– ident: e_1_2_22_10_1
  doi: 10.1016/S0304-3940(96)13264-X
– volume: 64
  start-page: 747
  year: 1993
  ident: e_1_2_22_25_1
  article-title: Pseudo‐hallucinations after long‐term lithium treatment [in German]
  publication-title: Nervenarzt
– ident: e_1_2_22_67_1
  doi: 10.1007/978-1-4615-3426-6_21
– ident: e_1_2_22_63_1
  doi: 10.1111/j.1471-4159.1977.tb10649.x
– ident: e_1_2_22_66_1
  doi: 10.1089/089771502753754091
– ident: e_1_2_22_20_1
  doi: 10.1111/j.1471-4159.1992.tb09273.x
– ident: e_1_2_22_19_1
  doi: 10.1016/0013-4694(83)90164-5
– ident: e_1_2_22_41_1
  doi: 10.1016/0028-3908(82)90180-0
– ident: e_1_2_22_68_1
  doi: 10.1111/j.1600-0773.1982.tb01054.x
– ident: e_1_2_22_30_1
  doi: 10.1111/j.1471-4159.1979.tb05179.x
– ident: e_1_2_22_47_1
  doi: 10.1016/S0028-3908(98)00024-0
SSID ssj0016461
Score 1.9091635
Snippet Studies were performed to determine if the reported ‘proconvulsant’ action of lithium in rats given cholinergic drugs is related to receptor‐initiated...
Studies were performed to determine if the reported 'proconvulsant' action of lithium in rats given cholinergic drugs is related to receptor-initiated...
Studies were performed to determine if the reported `proconvulsant' action of lithium in rats given cholinergic drugs is related to receptor-initiated...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1553
SubjectTerms Animals
arachidonic acid
Arachidonic Acid - administration & dosage
Arachidonic Acid - pharmacokinetics
Arachidonic Acid - physiology
Arecoline - administration & dosage
Autoradiography
Biochemistry and metabolism
Biological and medical sciences
Body Weight - drug effects
brain
Brain - drug effects
Brain - metabolism
Carbon Radioisotopes
Central nervous system
Cholinergic Agonists - administration & dosage
Drug Administration Routes
Drug Administration Schedule
Fundamental and applied biological sciences. Psychology
lithium
Lithium Chloride - administration & dosage
Male
muscarinic
phospholipase A2
Rats
Rats, Inbred F344
Rest - physiology
Seizures - chemically induced
Seizures - prevention & control
Signal Transduction - drug effects
Signal Transduction - physiology
stimulation
Time
Vertebrates: nervous system and sense organs
Wakefulness - physiology
Title Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats
URI https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1471-4159.2003.01811.x
https://www.ncbi.nlm.nih.gov/pubmed/12787074
https://www.proquest.com/docview/18935161
https://www.proquest.com/docview/73334869
Volume 85
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hXkBCPFqgKaX4gLhltbYTOzlWW0pViR4QlfYW-RV1tTS7YrPice0fZ8ZJtlpUpApxiXLIOIkz9nyOZ74P4J3KnQua16kSZZFihLKpzQuTeqMLU-YuyFhb9elCnV1m59N82uc_US1Mxw-x-eFGIyPO1zTAje1USMaR3ZYGucb1D8bjSOs5IuopPiI8yaUiGv2TzxsmKWLR4hvicHTUPqln2OC8q6GtSPV4aVbYaXWndnEXHN1GtzE8nT6F-fBiXVbKfLRu7cj9-oPz8f-8-TN40qNYdty53XN4EJpd2DtucAV__ZO9ZzGvNP6w34WHk0FTbg9uei5ehuD_ara-ZmaLu5ctFy1lLxH-ZZbEKxjRSV_NfDQybuYZJZwYqqFnpmUkLMJM41lXbcloLo_VjPHqQbmNUTvfzTwwvM3qBVyefvgyOUt7GYjUZVrxtJZhXJTaOemUsFY5EvT0IhdeCcez2nqMvt5KgQFZW8R3tQgeYZWjPd2gSvkSdppFE_aBCamk0kLY4H3mRWmdL4TGKSzo3EtXJKCHT165niOdpDq-VnGvPlNxraR5RX1PCp6yin1f_UiAbyyXHU_IPWyOtrzq1pBWkYi0E3g7uFmFH4q2ckwTFutVxRFm5gjW_36FllRjrcoEXnX-edu6oElaZwmo6GX3ft7q_GJCZwf_avgaHolOvTId80PYab-twxvEdK09iqMVjx-n_DfzpT59
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB5V9EClqg9oafoAH6resiV2YidHtAVtKeyhAolb5FfECsiuuln1ceWPM-MkixZRCVW95ZBxEmfs-ezxfB_AR5lZ61VSxZIXeYwRysQmy3XstMp1kVkvQm3V8ViOTtPDs-yskwOiWpiWH2K54UYjI8zXNMBpQ_pzl5bsRrnCBRAG5MDrOSDuqWSAgPJxiriDVmJfvi-5pIhHK1lSh6Ordsd6-hTnfS2txKqnMz3HbqtavYv7AOkqvg0B6uA5XPaf1p5LuRgsGjOwf-6wPv6nb38Bzzogy_Zaz3sJj3y9AZt7NS7ir36zTywcLQ179huwPuxl5TbhuqPjZYj_zyeLK6ZX6HvZbNrQASaCwMyQfgUjRunziQtG2k4cozMnmsromW4YaYswXTvWFlwyms5DQWO4uxdvY9TOT33hGT5m_gpOD_ZPhqO4U4KIbapkElfC7-aFslZYyY2RljQ9Hc-4k9wmaWUcBmBnBMeYrAxCvIp7h8jKUlrXy0K8hrV6Wvs3wLiQQirOjXcudbww1uVc4SzmVeaEzSNQ_T8vbUeTTmodl2VI16cyLJdUUlLfk4inKEPfl78iSJaWs5Yq5AE22ytudWtIC0kE2xHs9H5W4o-ibI6u_XQxLxNEmhni9b_foQSVWcsigq3WQW9b5zRPqzQCGdzswe9bHo6HdPX2Xw13YH10cnxUHn0df3sHT3grZhnvJu9hrfmx8B8Q4jVmOwzdG1pJQas
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9NAEB2hIgFSRaGFYijtHhA3h3rX3rWPVdqoFIgQolJv1n5ZjUKdiDji48ofZ2ZtpwoqUoW45eBZx-vZnbeemfcAXsnMWq-SKpa8yGOMUCY2Wa5jp1Wui8x6EXqrPozl6Xl6dpFddPVP1AvT8kOsPrjRygj7NS3wuavedFnJbpErPP9gPA60ngOinkoGiCfvphKBBQGkTysqKaLRSlbM4eipXVVPn-G8aaS1ULU51wuctaqVu7gJj67D2xCfRlsw7Z-sLUuZDpaNGdiff5A-_p9HfwQPOxjLjlq_ewx3fL0NO0c1HuGvfrDXLBSWhi_223B_2IvK7cCvjoyXIfq_nCyvmF4j72XzWUPlSwSAmSH1CkZ80pcTF4y0nThGFSeamuiZbhgpizBdO9a2WzLazEM7Y7i6l25jNM43PfUMb7N4Auejk8_D07jTgYhtqmQSV8If5oWyVljJjZGWFD0dz7iT3CZpZRyGX2cEx4isDAK8inuHuMpSUtfLQjyFjXpW-2fAuJBCKs6Ndy51vDDW5VzhHuZV5oTNI1D9Ky9tR5JOWh1fypCsT2U4LKmkpLknCU9Rhrkvv0eQrCznLVHILWz217zq2pCOkQi1Izjo3azEF0W5HF372XJRJogzM0Trf79CCWqylkUEu61_Xo_OaZdWaQQyeNmt_295Nh7Sr-f_angA9z4ej8r3b8fvXsAD3ipZxofJHmw0X5f-JeK7xuyHhfsbUBVAWg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+lithium+administration+potentiates+brain+arachidonic+acid+signaling+at+rest+and+during+cholinergic+activation+in+awake+rats&rft.jtitle=Journal+of+neurochemistry&rft.au=BASSELIN%2C+Mireille&rft.au=CHANG%2C+Lisa&rft.au=SEEMANN%2C+Ruth&rft.au=BELL%2C+Jane+M&rft.date=2003-06-01&rft.pub=Blackwell&rft.issn=0022-3042&rft.volume=85&rft.issue=6&rft.spage=1553&rft.epage=1562&rft_id=info:doi/10.1046%2Fj.1471-4159.2003.01811.x&rft.externalDBID=n%2Fa&rft.externalDocID=14875565
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon